Skip to main content
Fig. 2 | Alzheimer's Research & Therapy

Fig. 2

From: Alzheimer’s polygenic risk scores, APOE, Alzheimer’s disease risk, and dementia-related blood biomarker levels in a population-based cohort study followed over 17 years

Fig. 2

Baseline blood biomarker levels at baseline (before dementia diagnosis) according to APOE4 or PRS quartile. A, Baseline P-tau181 levels; B, Baseline NfL levels; C, Baseline GFAP levels. Q, quartile. Mann–Whitney U tests were used to test for statistically significant differences by APOE4 status or PRS quartile as indicated by: *p < .05; **p < .01

Back to article page

Alzheimer's Research & Therapy

ISSN: 1758-9193